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The fast developing international trade of products based on traditional knowledge and 42 
their value chains has become an important aspect of the ethnopharmacological debate. The 43 
structure and diversity of value chains and their impact on the phytochemical composition of 44 
herbal medicinal products as well as the underlying government policies and regulations have 45 
been overlooked in the debate about quality problems in transnational trade. Rhodiola species, 46 
including Rhodiola rosea L. and Rhodiola crenulata (Hook.f. & Thomson) H.Ohba, are used 47 
as traditional herbal medicines. Faced with resource depletion and environment destruction, R. 48 
rosea and R. crenulata are becoming endangered, making them more economically valuable 49 
to collectors and middlemen, and also increasing the risk of adulteration and low quality.  50 
 Rhodiola products have been subject to adulteration and we recently assessed 39 51 
commercial products for their composition and quality. However, the range of Rhodiola 52 
species potentially implicated is has not been assessed. Also, the ability of selected analytical 53 
techniques in differentiating these species is not known yet. 54 
Using a strategy previously developed by our group, we compare the phytochemical 55 
differences among Rhodiola raw materials available on the market to provide a practical 56 
method for the identification of different Rhodiola species from Europe and Asia and the 57 
detection of potential adulterants. Nuclear magnetic resonance spectroscopy coupled with 58 
multivariate analysis software and high performance thin layer chromatography techniques 59 
were used to analyse the samples. Rosavin and rosarin were mainly present in R. rosea but 60 
also in Rosea sachalinensis Borris. 30% of the Rhodiola samples purchased from the Chinese 61 
market were adulterated by other Rhodiola spp. The utilisation of a combined platform based 62 
on 
1
H-NMR and HPTLC methods resulted in an integrated analysis of different Rhodiola 63 
species. We identified adulteration at the earliest stage of the value chains, i.e. during 64 
collection as a key problem involving several species. This project also highlights the need to 65 
further study the links between producers and consumers in national and trans-national trade. 66 
 67 





While medicinal plants and spices have been traded for centuries on a global scale, the fast 71 
developing international trade of products now includes a large number of species which are 72 
used based on local and traditional knowledge and practice. The value chains of such 73 
products are starting to become an important topic in the ethnopharmacological debate. The 74 
structure and diversity of value chains, as well as their impact on the phytochemical 75 
composition of herbal medicinal products (HMPs) has been overlooked in quality issues in 76 
transnational trade. Different government policies and regulations governing trade in herbal 77 
medicinal products impact on such value chains.  78 
Medicinal Rhodiola species, including Rhodiola rosea L. and Rhodiola crenulata (Hook.f. 79 
& Thomson) H.Ohba, have been used widely in Europe and Asia as traditional herbal 80 
medicines with numerous claims for their therapeutic effects. Faced with resource depletion 81 
and environment destruction, R. rosea and R. crenulata are becoming endangered, making 82 
them more economically valuable to collectors and middlemen, and also increasing the risk 83 
of adulteration and low quality. Poor quality and adulterated Rhodiola rosea products have 84 
been previously reported (Booker et al. 2015, Xin et al. 2015) and this paper investigates 85 
some aspects of the value chains that leads to the production of such products. 86 
Adulteration of R. rosea products with R. crenulata has been previously reported but our 87 
fieldwork investigations suggested that other species may be implicated, and particularly 88 
Rhodiola sachalinensis, another species that appears to contain rosavins (the main marker 89 
compounds used for the identification of R. rosea). 90 
 91 
The genus Rhodiola (Crassulaceae) comprises approximately 90 species of succulent and 92 
herbaceous perennial plants, which mainly show a circumpolar distribution across the 93 
northern hemisphere (Xia et al. 2005, Lu. and Lan 2013). According to the Global 94 
Biodiversity Information Facility (GBIF, 2010) (Kylin 2010), Rhodiola species usually grow 95 
in mountainous areas such as rock ledges, precipices, tundra, brooks and river banks (Zhu 96 




Figure 1: Rhodiola species. A: R. rosea; B: R. crenulata; C: R. quadrifida; D: R. sachalinensis; E: R. fastigiata. 99 
Attribute: A & B: Anthony Booker; C: http://www.plantarium.ru/; D&E: Plant Photo Bank of China (PPBC) 100 
(http://www.plantphoto.cn/en)  101 
Ethnopharmacological importance of key  Rhodiola species: 102 
In Europe and North America, Sedum roseum (L.) Scop. (commonly named under its 103 
synonym R. rosea L.) is the most well-known and widely used among the different species. It 104 
is also known as golden root, or artic root which reputedly demonstrates the economic 105 
importance and the geographical distribution of the plant. It has a rich history of traditional 106 
use in Russia, Europe and Asia with various uses according to the region (e.g. as shown in 107 
Table 1).  108 
 109 
Table 1: Traditional uses of R. rosea in different regions 110 
Region  Use  Reference   
Russia  Escalation of physical 
endurance 
 Remedy against fatigue and 
high altitude sickness 
 Aphrodisiac 
Shikov et al., 2014; Alm, 2004 
Norway   Astringent 
 Cure for scurvy 
 Remedy against hair-loss and 
urinary tract disorders 
Alm, 2004 
Iceland and Denmark  Alleviation of headaches Alm, 2004 
  
France  Stimulant 
 Astringent 
Panossian et al., 2010 
Alaska  Cure for sores 
 Remedy against tuberculosis 
Alm, 2004 
Mongolia   Remedy against tuberculosis 
 Anticancer 
 Escalation of physical 
endurance 
 Treatment for lung 
inflammation 
Brown et al., 2002; World Health 




In Europe, the first documented medicinal use of R. rosea can be traced back to Dioscorides 112 
in 77 A.D. (Brown et al., 2002). In C. v. Linne’s Materia Medica, the root of R. rosea was 113 
recommended for several conditions such as headaches, ‘‘hysteria’’, hernias and discharges 114 
(C. v. Linne 1749 in Panossian et al., 2010). Throughout the years, it has appeared in many 115 
pharmacopoeias and medicinal books of different countries such as Sweden, France, Norway, 116 
Germany, Iceland, Estonia and Russia (Brown et al. 2002, Alm 2004, Panossian et al. 2010, 117 
Shikov et al. 2014). 118 
In China, 73 different Rhodiola species have been reported, mainly in the northwest and 119 
southwest regions such as Tibet and the Sichuan province. The adaptogenic and tonic 120 
properties of the Rhodiola plants have been widely used in traditional Chinese and Tibetan 121 
medicine (Li and Zhang, 2008). They are generally referred to with the Pinyin name Hong 122 
Jing Tian 红景天 (red (or glorious) view of heaven) with slight alterations for each species. 123 
(Table 2). 124 
 125 
Table 2: Examples of the similar Pin Yin names of different Rhodiola species in China 126 
Scientific name Pin Yin name 
R. rosea L. Qiang Wei (rose smell) Hong Jing Tian  
R. sachalinensis Borris. Gao Shan (high mountain) Hong Jing Tian 
R. quadrifida (Pall.) Fisch. & C.A.Mey Si Lie (four split) Hong Jing Tian 
R. crenulata (Hook.f. & Thomson) H.Ohba Da Hua (big flower) Hong Jing Tian 
R. yunnanensis (Franch.) S.H. Fu Yunnan (From Yunnan) Hong Jing Tian 
R. kirilowii (Regel) Maxim. Xia Ye (narrow leaf) Hong Jing Tian 
R. fastigiata (Hook. f. & Thomson) S.H. Fu Chang Bian (clustered) Hong Jing Tian 
 127 
R. crenulata can be traced back to Tibetan medicine books including ‘‘The Four Medical 128 
Tantras’’ (rgyud-bzhi in Tibetan, Si Bu Yi Dian in Chinese), Yue Wang’s Classical Medicinal 129 
Book (Somaratsa in Tibetan, Yue Wang Yao Zhen in Chinese) and Jing Zhu Materia Medica 130 
(Shel Gong Shel Phreng in Tibetan, Jing Zhu Ben Cao in Chin ese (Lu. and Lan 2013)). It is 131 
used for treatment of cough, hemoptysis, pneumonia and abnormal vaginal discharge. In 132 
Traditional Chinese Medicine (TCM), it has effects of nourishing qi as well as promoting 133 
blood circulation and is mainly prescribed for qi deficiency and blood stasis (QDBS), stroke, 134 
hemiplegia and fatigue. It is commonly used in China and Tibet for treating altitude sickness. 135 
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Phytochemical and pharmacological research: 136 
Research on the phytochemistry and pharmacology of Rhodiola spp. was initiated in the 137 
1960s in the Soviet Union and Scandinavia, mainly focusing on R. rosea (Brown et al., 2002). 138 
After the turn of the century the interest in this plant spread globally. Intensive phytochemical 139 
research led to the detection of known and novel compounds in R. rosea and related species 140 
(Ma et al., 2006; Yousef et al., 2006). Between 2000 and 2015 an increased number of 141 
publications stemming from Asian research groups have focused on the detection of novel 142 
compounds from Rhodiola species, usually in combination with their respective 143 
pharmacological assessments (Fan et al., 2001; Nakamura et al., 2007; Nakamura et al., 144 
2008). 145 
There are more than a few hundred pharmacological studies on medicinal Rhodiola 146 
species (mainly on R. rosea) that show a wide range of activities reflecting their diverse 147 
traditional use. They possess adaptogenic and stress-protective (neuro-cardio and hepato 148 
protective); cardioprotective; antioxidant effects as well as stimulating effects on the central 149 
nervous system including on cognitive functions such as attention, memory and learning; 150 
anti-fatigue effects; antidepressive and anxiolytic effects; endocrine activity normalising; life-151 
span increasing effects. (Aslanyan et al. 2010, Sarris et al. 2011, Panossian et al. 2013). The 152 
main active compounds are reputedly phenylpropanoids (rosavin, rosarin, rosin) and 153 
phenylethanoids (salidroside and tyrosol). 154 
Quality issues of medicinal Rhodiola spp. 155 
Rhodiola roots and rhizomes are highly valuable products traded at an international level. 156 
Since the majority of R. rosea and R. crenulata raw material supplied still comes from wild-157 
collection their intensive collection leads to scarcity. (Galambosi, 2006; (Lu. and Lan 2013) 158 
 Herbal preparations of Rhodiola species (mainly R. rosea) are extensively utilised around 159 
the globe. There is an increasing number of commercial products available on the American, 160 
Asian and European markets, either as food supplements or herbal medicines. R. rosea herbal 161 
monographs have been included in many Pharmacopoeias worldwide. On the other hand, R. 162 
crenulata is the only species used medicinally in TCM (Table 3). 163 
Due to this rapid increase of Rhodiola raw material demand, other Rhodiola species such 164 
as R. fastigiata, R. sahcalinensis, R. quadrifida, Rhodiola sacra (Prain ex Hamet) S.H.Fu and 165 
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Rhodiola serrata H. Ohba have been sold on the market (Xin et al. 2015). Since there is not 166 
any consistent worldwide quality control programme, inadequate quality assessment of 167 
Rhodiola spp. is a common issue. This raises concerns about possible adulteration and 168 
misidentification issues. The lack of genuine drug material, confusion over the Chinese Pin 169 
Yin name of the drug when sourcing from China and accidental or deliberate adulteration 170 
during the manufacturing stage may contribute to low quality of final products.  171 
The analytical techniques currently available focus on identifying R. rosea or R. crenulata 172 
through chromatographic methods. Other species of  Rhodiola have generally not been 173 
considered. R. sachalinensis presents a particular problem as it may contain similar marker 174 
compounds to R. rosea. (and some sources suggest that it is the same species – see 175 
www.kew.org/mpns-portal) 176 
 177 





Medicinal use part Herbal product 
Department of Health and 
Ageing, Australian 
Government 
Rhodiola rosea Root (Rhizome) Dry extract 








Rhodiola rosea Rhizome et radix Dry extract, tincture 
Chinese Pharmacopoeia 
(2010) 
Rhodiola crenulata Rhizome et radix Extract 
Russian Pharmacopoeia 
(12th Edition) 
Rhodiola rosea Rhizome et radix Extract 
 179 
 180 
Integrated analytical platform approach  181 
NMR-based metabolomics  182 
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NMR-based metabolic fingerprinting has been used in numerous food and medicinal 183 
species focusing on their quality assurance as well as their pharmacology. Such comparative 184 
studies include Danggui [Angelica sinensis (Oliv.) Diels] and Engelwurz / European 185 
Angelica (Angelica archangelica L.) (Li et al. 2014). Metabolomic differences between 186 
different Tussilago farfara L. accessions (Zhi et al. 2012) and different Salvia miltiorrhiza 187 
Bunge production sites (Jiang et al. 2014) were also studied by NMR fingerprinting coupled 188 
with multivariate analysis. Compared to GC-MS and LC-MS, NMR has some advantages 189 
such as non-selectiveness, high reproducibility, and good stability (Simmler et al. 2014). At 190 
the same time, structural information on metabolites could also be obtained from NMR 191 
directly. Therefore, NMR could be regarded as an ideal choice for chemical comparison and 192 
identification of the phytochemical differences of medicinal plants. 193 
 194 
HPTLC 195 
Since the NMR- metabolomic approach is not a validated pharmacopoeial method, there is 196 
a need to be compared to a standard method like high performance thin layer chromatography 197 
(HPTLC). This method is widely used for the authentication and quality control of herbal 198 
substances (Reich et al. 2008). Compared to NMR-based metabolic fingerprinting, HPTLC 199 
could be highly effective with relatively lower price (Booker et al. 2014). HPTLC can also be 200 
helpful for the identification of specific compounds. Therefore, we chose these two 201 
complementary approaches in this study. 202 
A third analysis strategy using DNA bar coding was used to help verify some of the 203 
samples (details are given in the supplementary material (S2)). 204 
Material and methods 205 
Sampling and preparation of plant material 206 
42 batches of Rhodiola market samples (i.e. not authenticated) were collected between 207 
October 2014 and January 2015 from different suppliers including retail outlets, Internet, 208 
pharmaceutical companies in seven different locations (Beijing, Guangdong, Qinghai, Anhui, 209 
Hebei, Jilin and Hong Kong SAR) in China, Germany and Russia. These raw-material 210 
samples, were mainly labelled as R. rosea, R. crenulata, R. sachalinensis and R. quadrifida. 211 
18 batches of authenticated plant material were provided by Agroscope institute 212 
P vis
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(Switzerland). The samples were rhizomes of R. rosea plants propagated from different wild 213 
Swiss populations (Mattmark, Carrasino, and Nomnon) or botanical gardens (Switzerland and 214 
Germany). In addition, authenticated R. rosea samples which were grown from seeds or 215 
provided to the institute by Dr. Bertalan Galambosi were also included. Lastly, in July 2015, 216 
samples of R. crenulata and R. fastigiata roots and rhizomes were collected from Garze, 217 
Sichuan, China (altitude 4,500 metres). These samples were authenticated by Professor 218 
Shuyuan Li, (Guangdong Pharmaceutical University, Guangzhou, China). Botanical 219 
reference materials (BRMs) for R. rosea, R. crenulata and R. sachalinensis were obtained 220 
from the National Institute of Food and Drug Control (NIFDC, China), Dr. William Schwabe 221 
(Germany) and Agroscope (Switzerland). BRMs for R. quadrifida and R. fastigiata were 222 
provided by Professor Alexander Shikov (Saint-Petersburg Institute of Pharmacy, Russia) 223 
and Dr. Anthony Booker (UCL School of Pharmacy- R. fastigiata authenticated by Professor 224 
Shuyuan Li, Guangdong Pharmaceutical University, Guangzhou, China), respectively. 225 
All the collected samples were deposited in the herbarium of the UCL School of Pharmacy 226 
(London, UK). A detailed description of the investigated samples including their origins and 227 
representative symbols are provided in supplement (S1).  228 
Crude root samples were ground to powder using a household grinder (EK1665ROFOB, 229 
Salter, UK) and sieved (0.70 mm mesh). All the powder samples were kept in 1.5 mL tubes 230 
(Eppendorf AG.) at 4 °C until use. 231 
Solvents, reagents and reference compounds 232 
Deuterium oxide (D2O), methanol-d4 (99.8% D, MeOD), dimethyl sulfoxide-d6 (DMSO-d6) 233 
and tetramethylsilane (TMS) were obtained from Cambridge Isotope Laboratories Inc. 234 
(Andover, MA). Salidroside, gallic acid, rosarin and rosavin were purchased from Sigma-235 
Aldrich Chemicals (St Luis, USA). Tyrosol was purchased from Acros organics (New Jersey, 236 
US). Water used in this study was purified by using ULTRAPURE water system (Millipore, 237 
Germany). All other chemicals were of analytical grade. 238 
1
H-NMR spectroscopy 239 
Sample preparation 240 
900 μL of MeOD-d4 was added for extraction. The samples were vortexed (Rodamixer, UK) 241 
for 30 s and sonicated at an ultrasound bath (Fisher, XB22, UK) for 10 min. The solutions 242 
Provis
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were centrifuged for 10 min at 14,000 rpm (EBA21, Hettich, Faust Laborbedarf AG, 243 
Germany). 600 μL of supernatant was transferred to a 5mm diameter NMR spectroscopy tube 244 
and the samples were submitted for NMR spectroscopic analysis. The one and two 245 
dimensional 
1
H-NMR spectra were recorded on Brucker Avance 500 MHz spectrometer 246 








H) 5mm 247 
cryoprobe. The acquisition parameters were: size of the spectra 64 k data points, line 248 
broadening factor = 0.16 Hz, pulse width (PW) = 30 degrees and the relaxation delay d1 = 1 s. 249 
The acquisition temperature was 298 K. 250 
In order to assess the coherence of the results obtained, two samples from the same batch 251 
were subjected to NMR analysis on the different days of examination. To minimize the error 252 
caused by root selection during sample grinding, any samples weighed more than 500g were 253 
analysed twice.  254 
Data analysis 255 
The resulting spectra were manually phased and automatic baseline corrected by Topspin 256 
3.2 (Bruker, Germany) for organic fractions. Signals between δ 5.20 - 4.40 ppm and δ 3.35 - 257 
3.22 ppm were removed prior to statistical analysis due to the presence of methanol-d4. The 258 
total area of peaks (δ 10.00 - 0.00 ppm) was integrated into small (0.04 ppm) buckets by 259 
bucketing (binning) function using AMIX or ACD-Labs in order to generate a number of 260 
integrated regions of the data set. The buckets obtained were then imported to Microsoft 261 
EXCEL (2013) where the samples were re-labelled and their species information was added.  262 
Principal component analysis (PCA) was performed with SIMCA-P 13.0 (Umetrics, Umeå, 263 
Sweden) for metabolomic analysis of the generated dataset. Scaling mode of Pareto (Par) and 264 
Unit Variance (UV) were tested to optimize the analysis model with best R
2
X value. 265 
HPTLC  266 
Sample preparation  267 
1 ml of ethanol was added to 50mg of weighed samples for extraction. The solutions were 268 
then mixed on a rotary mixer (Rodamixer, UK) for 30 s, sonicated in an ultrasound bath 269 
(Fisher, XB22, UK) for 10 min and centrifuged for 10 min at 14,000 rpm. The supernatant 270 
was used for HPTLC analysis. The reference standard solutions of salidroside, rosarin, 271 
Provis
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rosavin, gallic acid and tyrosol were prepared at a concentration 1mg/mL in methanol. Both 272 
the reference material and the test samples were stored at 4
o
C. 273 
Data analysis  274 
Samples were applied to the plates as bands 8 mm wide by using Linomat 5 semi-275 
automatic applicator with 100 μL syringe. The space between bands was 2.0 mm and the rate 276 
of application was 90 nL∙ s–1. The number of tracks per plate was 15 and 5μl of standard and 277 
sample solution were applied. 278 
The temperature and relative humidity were controlled to 21-24°C and 33 %, respectively. 279 
10 mL solvent was poured into the right inlet for development and 25 mL solvent was poured 280 
into the left inlet for saturation. Plates were previously air dried for 10 s and developed in a 281 
20 cm × 10 cm twin-trough chamber (Analtech, USA) lined with Whatman filter paper (20 282 
cm × 10 cm) and saturated with mobile phase (Ethylacetate, methanol, water, formic acid 283 
(77:13:10:2) vapour for 20 min. The development distance was 70.0 mm from the lower edge. 284 
The developed plates were derivatised by dipping in sulphuric acid reagent, using a 285 
CAMAG chromatogram immersion device and heated at 100°C on a plate heater for 5 min. 286 
Sulphuric acid reagent was prepared with procedure as follow: 20 mL sulfuric acid was 287 
carefully added to 180 mL ice-cold methanol and mixed. The plates were visualised using 288 
CAMAG visualizer under white light, UV 254 nm and at UV 366 nm, photographed and 289 
uploaded to HPTLC computer software (VisionCats).  290 
Results and discussion 291 
 
1
H-NMR and multivariate statistical analysis  292 
By incorporating the whole region (0-10 ppm) and Par scaling a significant clustering is 293 
observed in R. rosea samples (Figure 2). R. rosea can be differentiated distinctly from the rest 294 
of the species based on their principal component variability.  295 
Figure 2: Scores plot of five different species of Rhodiola (R. rosea, R. crenulata, R. quadrifida, R. 296 
sachalinensis, R. fastigiata),  showing principle component 1  and principal component 2. 297 
According to the spectra of the species (Figure 3), the aromatic region (6-8 ppm) is 298 
dominated by the main marker compounds (rosavin and salidroside). Hence, this region was 299 
Pr vis
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analysed independently using Par scaling (Figure 4). Based on the scores plot produced, 300 




H-NMR spectra of the reference compounds, salidroside and rosavin, together with the spectra of 303 
botanical reference material. 1: R. fastigiata, 2: R. quadrifida, 3: R. crenulata, 4: R. sachalinensis, 5: R. rosea, 304 
6: rosavin and 7: salidroside.(From bottom to top) A: Whole region (0-10ppm); B: aromatic region (6-8ppm) 305 
 306 
Figure 4: Scores plot of Rhodiola samples using the aromatic 
1
H-NMR region and Pareto scaling 307 
 308 
R. crenulata and R. quadrifida were also separated from the rest of the species. However, in 309 
this model they were clustered together. This means that there is no crucial metabolomic 310 
difference between them in the aromatic region. At this point it was considered important to 311 
visually inspect the spectra of the BRM’s and detect any differences that they might be gone 312 
with the integration of the data. R. crenulata BRM has an additional quartet at 6ppm not 313 
detected in the rest of the species. This quartet can also be found in all the other R. crenulata 314 
samples investigated (figures not shown). 315 
Therefore, an effective separation between R. crenulata and R. quadrifida samples can be 316 
accomplished by combining the PCA results with the detection of the additional peaks on the 317 
1
H-NMR spectra only present in R. crenulata samples between 5-6ppm. 318 
We also studied the group-pair comparisons in PCA model with Pareto scaling (Figure 5). 319 
The score plots showed that Rhodiola species separated well. (A: R. crenulata with other 320 
Rhodiola species; B: R. rosea with other Rhodiola species; C: R. crenulata with R. rosea). 321 
 322 
Figure 5: Score plots of group comparison between Rhodiola species. A: R. crenulata (red) with other Rhodiola 323 
spp. (blue); B: R.rosea (green) with other Rhodiola spp. (blue); C: R. crenulata (red) with R. rosea (green). 324 
The main differences were between δ 7.5 - 7.3 ppm (PC1) and δ 7.0 - 6.8 ppm (PC2). The 325 
chemical shift of the main variable metabolites were mainly rosavin, rosarin and cinnamyl 326 
alcohol derivatives. 327 
 The metabolites detected were elucidated by the analyses of the 
1
H-NMR spectra as well 328 
as the comparison with the reference compounds, together with the in-house NMR chemical 329 
Provi
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shift database (Mudge et al. 2013, Luo et al. 2015). The summary of the assignment of 
1
H-330 
NMR spectral peaks obtained from the R. rosea, R. crenulata and R. sachalinensis BRM 331 
extracts are provided in supplement (S3).  332 
 333 
 334 
HPTLC analysis  335 
The band position and visibility of the standards rosavin, rosarin and salidroside (Figure 7) 336 
appear with characteristic colours and increasing retention factors (Rfs) 0.19, 0.26 and 0.31 337 
respectively Fig.7, track H). Under UV light 254nm (track D), salidroside is not visible. 338 
Under 366nm, after derivitisation with sulphuric acid, rosavin and rosarin appear as pale pink 339 
bands and salidroside as a green one (track H).  340 
Gallic acid shows good visibility under UV 254 nm (track A), while it is not easily 341 
detected under UV 366 nm at a dark blue back-round (track E). Tyrosol is visible in 254 nm 342 
but less clear in 366 nm.  343 
 344 
 345 
Figure 6: Left: HPTLC results of standard compounds under UV 254 nm (rosavin Rf = 0.19, rosarin Rf = 0.26, 346 
gallic acid Rf = 0.58); Right: HPTLC results of standard compounds under UV 366 nm, after derivatisation 347 
with sulphuric acid (rosavin Rf =0.19, rosarin Rf = 0.26, salidroside Rf = 0.31, gallic acid Rf = 0.58, tyrosol Rf 348 
= 0.76) 349 
The raw plant material obtained from the market was also studied by our HPTLC method 350 
(list of samples in Supplement S4). Under UV 254 nm (Fig. 8), there were two obvious bands 351 
among these samples (Rf= 0.27 and 0.48). However, due to lack of reference standards, their 352 
identity remains unknown. Further studies need to be conducted using NMR and TLC-MS. 353 
The majority of the samples investigated contained concentration of tyrosol similar to the 354 
standard raw material used (R24, R30 and R31). Samples R1-R6 contained lower levels of 355 
this compound possibly due to their longer storage time. Therefore, tyrosol could be 356 
considered as a marker to study duration of Rhodiola storage. It was also found that only five 357 
samples (R9, R25, R58, R59 and R24) contained high levels of rosavin, which turned out to 358 
be R. rosea. Moreover, this result can also be verified by the NMR results (Figure 5). 359 
However, it is not evident whether there is adulteration of R. sachalinensis in R. rosea since 360 
their metabolites are similar.   361 
Prov s
io al
Under UV 366nm after derivatisation eight samples (R1, R5, R6, R15, R27, R32, R61 and 362 
R64) had low content in salidroside (Rf = 0.31). These samples could have been kept for 363 
rather long time after collection and the salidroside content could have decreased due to lack 364 
of good storage environment.                                       365 
 366 
 367 
Figure 7: HPTLC results for all Rhodiola market samples, mobile phase (Ethylacetate, methanol, water, formic 368 
acid (77:13:10:2) 369 
 370 
Combining the results of HPTLC and 
1
H-NMR multivariate statistical analysis, we also 371 
analysed the adulteration rate among all the market samples (supplement, S4).  372 
30% of the Rhodiola samples collected from the market were not R. rosea or R. crenulata. 373 
Some R. rosea samples were also being sold as R. crenulata. 47.7 % of raw materials samples 374 
were not labelled properly and their species information were not clearly illustrated to 375 
customers. This highlights the lack of proper local government policies and good quality 376 
control strategies. 377 
According to our study, different Rhodiola species (including R. rosea and R. crenulata) 378 
can be found in the Chinese market. However, they are neither sold separately nor well 379 





Qualitative and quantitative analysis of mixtures  385 
 386 
Since in the value chain mixing of batches and, therefore, potentially also of species also is of 387 
major concern, the possibility of qualitatively and quantitatively detecting plant mixtures was 388 
also investigated. The additional species chosen for this study was R. crenulata which is 389 
considered to be the most common adulterant of R. rosea. The selected BRMs were weighed 390 
individually in different proportions and then added together in an Eppendorf reaction tube. 391 





spectroscopy. The samples were renamed as seen in Table 4. After the acquisition of the 393 




H-NMR-based detection of plant mixtures by  396 
Sample name  Mg of R. rosea BRM Mg of R. crenulata BRM 
RR100  100 00 
RR80RC20  80 20 
RR60RC40  60 40 
RR40RC60  40 60 
RR20RC80  20 80 
RC100  00 100 
 397 
In all samples, the salidroside peak intensity remains almost the same since this constituent is 398 
present in both species. The peaks of rosavin are gradually decreasing with the addition of R. 399 
crenulata, whereas the characteristic quartet at 6ppm due to the presence of an unknown 400 
compound is increasing with the addition of R. crenulata and it is not detected in R. rosea at 401 




H-NMR spectra of the whole region (left) and the aromatic region (right) of the R. rosea and R. 404 
crenulata mixtures  405 
 406 
The acquired spectra were bucketed using Amix and only focused on this region (6ppm). 407 
When the whole quartet was integrated into a single bucket, the observed increase of its 408 
intensity was not adequately represented. Therefore, the bucket size used changed to 0.02ppm 409 
and only incorporated the first peak of the quartet (6.0028-6.0048ppm). The buckets obtained 410 
from Amix when then transferred into Excel, where the relationship between the bucket value 411 
and the percentage of R. crenulata in the mixture was expressed graphically as a calibration 412 
curve. The bucket value of the respective peak is increasing in a linear mode (Figure 10).  413 
 414 
 415 
Figure 9: Calibration curve showing the bucket value of the peak versus the percentage of R. crenulata within a 416 




Similar results can also be obtained with HPTLC analysis. The HPTLC fingerprints produced 419 
consist of the over-spotted BRM extracts in different volumes as seen in Table 5. The final 420 
volume applied was 5 μL. 421 
 422 
Table 5: Sample preparation for the detection of plant mixtures by HPTLC 423 
R. rosea 100% RR100 R. rosea BRM 5μL 
R. rosea 80% and R. 
crenulata 20% 
RR80 R. rosea BRM 4μL 
R. crenulata BRM 1μL 
R. rosea 60% and R. 
crenulata 40% 
RR60 R. rosea BRM 3μL 
R. crenulata BRM 2μL 
R. rosea 40% and R. 
crenulata 60% 
RR40 R. rosea BRM 2μL 
R. crenulata BRM 3μL 
R. rosea 20% and R. 
crenulata 80% 
RR20 R. rosea BRM 1μL 
R. crenulata BRM 4μL 
R. crenulata 100% RC100 R. crenulata BRM 5μL 
 424 
As seen in Figure 11, when the loading volume of the R. rosea decreases, the representative 425 
markers of this species (rosavin and rosarin) decrease as well. However, the band for 426 
salidroside, (since it occurs in both species) remains almost the same. 427 
 428 
Figure 10: HPTLC fingerprints of all R. rosea and R. crenulata mixtures under UV 254nm (tracks 1-6), white 429 
light and SAR (tracks 7-12) and UV 366nm and SAR (tracks 13-18). 430 
 431 
By gradually increasing the R. crenulata proportion, several bands gradually appear above 432 
salidroside that could potentially be used as markers for the qualitative and semi-quantitative 433 
HPTLC analysis of mixtures of these two Rhodiola species. Further work needs to be carried 434 





This study provided a method for distinguishing five different species of Rhodiola and 438 
suggests possible methods for quantifying different species within mixtures. The 439 
metabolomic and phytochemical differences between these different species has been 440 
demonstrated through NMR spectroscopy and HPTLC analysis. Species represented with 441 
only a small number of samples will need further investigation in order to accurately define 442 
their chemical characteristics.  443 
 There is a need to study the links between producers and consumers especially when in 444 
trans-national trade and re-enforce the hypothesis that poor quality and adulterated products 445 
can be products of poorly governed value chains, particularly at the early stages of supply. 446 
Moreover, it can be argued that through the establishment of well-controlled and well 447 
managed value chains it is possible to better prevent accidental or deliberate contamination 448 
and adulteration from occurring 449 
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